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Abstract: 
Background: In the US there are over 2.5 million breast cancer survivors (BCSs), most of whom have required some type of intensive 
treatment. How individuals cope with the treatment process may relate to why neurocognitive problems arise.
Method: We explored the impact of treatment for breast cancer (BC) on performance of the Memory Island task, both on working mem-
ory and on the general index of cognitive performance in relation to coping strategies of BCSs compared to age-matched controls.
Results: The evidence obtained suggests a reduced performance in visuospatial memory in BCSs. Those who used emotional coping 
strategies displayed reduced performance in visuospatial learning and immediate memory. Those women who used problem-  focused cop-
ing strategies performed better in those tasks measuring psychomotor speed, general intelligence, and delayed visuospatial memory.
Conclusions: It is concluded that further investigation of the relationship between coping strategies and performance on visuospatial 
tasks may provide useful information on residual levels of neurocognitive deficits and psychosocial adaptation in BCSs.
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Introduction
Investigations conducted by the American Cancer 
Society  indicate  that  there  are  2.5  million  breast 
cancer survivors (BCSs) in the United States. This 
means that 1 out of 8 women can expect to be diag-
nosed with some form of breast cancer (BC) at some 
point in their life.1,2 Among Puerto Rican women, 
BC is the most commonly diagnosed type of can-
cer, accounting for 33% of all cancer diagnoses from 
1999 to 2003.3 Statistics from the Division of Epide-
miology of the Department of Health of Puerto Rico 
indicate that approximately 1,540 women are diag-
nosed annually and that the survival rate of these 
women is 76.4%.2,3 Consequently, understanding the 
long-term consequences of BC and its treatments 
becomes  an  important  challenge  for  health-care 
providers.
Chemo-brain  and  chemo-fog  are  the  colloquial 
terms  used  to  describe  the  phenomenon  of  cogni-
tive decline that some patients may experience after 
chemotherapy.4,5 It has mainly been studied in BC 
patients because of their high survival rate as well 
as  in  younger  and  middle-aged  women  who  com-
plain  of  cognitive  decline.  Several  investigations 
have shown impairments in visuospatial learning and 
memory following chemotherapy in long-term can-
cer survivors.6–9 Animal studies also indicate the exis-
tence of impairments in the performance of spatial 
learning and memory tasks following treatment with 
methotrexate or 5-fluorouracil, the most commonly 
used chemotherapy agents.10–12
Chemotherapeutic  agents  are  administered  in 
period cycles, orally or intravenously. The chemicals 
move through the bloodstream, destroying malignant 
cells in different phases of their growth.13 However, 
anything that is poisonous to cancer cells may also 
be  poisonous  to  other,  healthy,  cells  in  the  body. 
Researchers have hypothesized that the toxicity of 
chemotherapy  drugs  can  affect  blood  vessels  and 
eventually cross the blood-brain barrier, allowing high 
concentrations of chemicals to reach several cortical 
brain areas.9 Although the neurotoxicity mechanisms 
leading to cognitive deficits are not well understood, 
evidence suggests that those chemicals used in che-
motherapy for BC may induce negative effects on the 
brain tissue and neurotransmitters involved in cogni-
tive processing.14–16
Findings regarding cognitive impairment in women 
with a history of chemotherapy are inconsistent, indi-
cating that several neuropsychological domains such 
as, attention and, spatial ability, visual memory, and 
working memory, are affected by high and even stan-
dard doses of chemotherapy.16 Studies on BCSs have 
reported cognitive impairment as long as 5 to 10 years 
after  completion  of  chemotherapy.17–20  In  addition, 
women who received chemotherapy and Tamoxifen 
(hormonal treatment), scored lower in visual mem-
ory and verbal working memory.21 Considering the 
complications and cofounders involved in studying 
BCSs, pre-clinical models are vital to understand the 
possible side effects of chemotherapy, including neu-
rocognitive impairments.
Most of the standardized neuropsychological tests 
used to assess chemotherapy’s impact on long-term 
working memory and visual spatial memory8,19 are 
not translatable to pre-clinical models. As the Morris 
water maze is the most commonly used and recog-
nized pre-clinical learning and memory animal task, 
a translation and validation of a human version of a 
visuospatial  memory  task,  such  as  Memory  Island 
(MI),22,23 is necessary. Correlations between MI and 
other standardized tests suggest that it encompasses 
motor coordination, picture recognition, visual work-
ing memory, and visuospatial memory.22,24 MI can be 
an appropriate measure of visuospatial learning and 
memory suitable for use in other cultures. MI ade-
quately assesses depth perception, visuospatial atten-
tion, figure-ground discrimination, spatial perception, 
and orientation. Furthermore, MI tasks can be utilized 
as a quantitative and qualitative measure that mimics 
pre-clinical assessments.
BCSs often experience physical, emotional, and 
social difficulties that can prolong psychological stress 
due to the impact of the disease and its treatment dur-
ing the remission period.25–27 Stress emerges from an 
imbalance between the requirements of the environ-
mental situation and the person’s ability to cope with 
that situation.28 According to the transactional model 
of stress and coping, stress is conceptualized as the 
appraisal induced by the interaction between an indi-
vidual  and  the  environment  when  confronted  with 
situations that exceed the individual’s resources.29,30 
The theory states that cognitive appraisal and cop-
ing strategies are the processes that mediate those Spatial memory and coping in breast cancer survivors
Breast Cancer: Basic and Clinical Research 2011:5  119
stressful  transactions  (individual-environment)  and 
therefore  will  determine  the  immediate  and  long-
term perception and reactions toward a stressful situ-
ation. The person first recognizes a stressful situation 
as troublesome (primary appraisal); next, the person 
evaluates and determines what resources are required 
in order to overcome or handle the problem (second-
ary appraisal). The individual engages in cognitive 
and behavioral attempts to reduce, minimize, or toler-
ate the internal and external demands of the appraised 
transaction.29
The process of coping has two major functions: 
dealing with the problem that is causing the stress 
(problem-focused)  and  regulating  emotional  states 
(emotion-focused).  The  aim  of  problem-focused 
strategies is to cope with stress by acting directly on 
its cause; such strategies usually consist of an indi-
vidual’s attempting to resolve or alter the source of 
their stress by removing or alleviating the stressor. 
Some  examples  of  problem-focused  strategies  are 
active  coping,  planning,  suppression  of  competing 
activities, and restraint.31 On the other hand, emotion-
focused coping strategies are directed toward reduc-
ing  or  managing  the  emotional  distress  associated 
with a stressful situation. These strategies predomi-
nate when people appraise a situation as something 
that must be endured.28 Some examples of emotion-
focused strategies are positive reinterpretation, denial, 
acceptance, use of emotional social support, and turn-
ing to religion.31
In  a  longitudinal  study,  coping  strategies  were 
assessed in women who had completed chemother-
apy for BC from 4 weeks to 4 months prior to the 
assessment.32 The results demonstrated that partici-
pants utilized acceptance, religion, and distraction as 
their primary coping strategies.32 This suggests that 
they  incline  toward  using  emotion-focused  strate-
gies as being the more effective strategies in dealing 
with psychosocial situations soon after completing 
  chemotherapy.  Understanding  and  knowing  what 
coping strategies have been engaged by cancer sur-
vivors will enhance the development and outcomes 
of cognitive-behavioral treatments, improving mental 
health and general well-being.33,34
Culturally, there are differences among the types 
of coping strategies that BCSs of different minority 
groups use in order to manage stressful situations.35 
Studies indicate that Latina BCSs tend to use more 
spiritual styles of coping and have a greater need for 
social support.36–38 Researchers highlight the impor-
tance  of  further  understanding  the  psychological 
aspects of coping that are necessary to managing and 
reducing emotional distress in BCSs.35 Nevertheless, 
there appears to be insufficient information available 
on Hispanic patients regarding what coping strate-
gies are more effective in dealing with the long-term 
consequences of chemotherapy treatment, and which 
strategies can have a direct impact on a given survi-
vor’s overall quality of life.36
Method
Participants and recruitment
The data collected was part of Dr. Summer   Acevedo’s 
research  project  titled  “Effect  of ApoE  on  Spatial 
Learning and Memory in Hispanic Cancer Survivors” 
and sponsored by the Moffitt Cancer Center. A total 
of 38 participants from an existing data base were 
analyzed. The sample consisted of 16 BC women in 
remission (at the time of the study) who had received 
chemotherapy and 22 women who had either never 
been diagnosed with BC or who had not received 
chemotherapy.  The  identities  of  the  subjects  were 
maintained in strict confidentiality following HIPAA 
guidelines  and  regulations.  Release-of-information 
consent was approved by the Ponce School of Medi-
cine Institutional Review Board. Prospective partici-
pants between 30 to 65 years of age were contacted 
at health fairs, cancer support groups, and Relay for 
Life annual walks, sponsored by the American   Cancer 
Association, at various locations in Puerto Rico. An 
interviewer contacted the individuals interested in the 
study in order to complete a telephone questionnaire 
and  determine  their  eligibility.  To  be  eligible,  the 
BCSs must have concluded chemotherapy for non-
metastatic BC at least six months prior to the study. 
Any woman with a history of a major psychiatric dis-
order, a neurological or medical disease, or a severe 
vision or hearing impairment was excluded from the 
investigation.  Information  regarding  demographics, 
level of education attained, duration of illness, and 
type of chemotherapy received was gathered if inclu-
sion  criteria  were  fulfilled.  Follow-up  phone  calls 
were also made to arrange an evaluation date. Socio-
demographic information and level of education were Ayala-Feliciano et al
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matched with women who were not diagnosed with 
any type of cancer.
Procedures
All neurocognitive testing was conducted by research 
assistants. Participants were tested in a single visit 
that lasted approximately two hours. The evaluations 
were conducted in a designated clinical room at the 
Psychoneurometrics Research Building at the Ponce 
School of Medicine. Ten-minute breaks between tasks 
were  authorized  at  the  discretion  of  each    subject. 
  Participants were allowed to end the evaluation or 
leave the project at any moment.
Conners’ Continuous Performance Test 
(CPT-ii)
For  the  non-verbal  computerized  attention  task, 
respondents  were  required  to  press  the  space  bar 
when any letter except the target letter X appeared.39 
The  CPT-II  software  program  measures  response 
time,  omission  and  commission  errors,  change  in 
reaction-time and consistency.39 The software con-
tains  large  normative  samples,  including  clinical 
data on ADHD sufferers and neurologically impaired 
adults. The results, based on T-scores and percentiles 
and  relative  to  both  the  general  population  (non-
clinical sample) and an ADHD clinical sample, were 
recorded.  Automatically  generated  scoring  sheets 
were printed out for analysis after CPT II adminis-
tration. The non-clinical score was used as an overall 
measure of attention.
grooved Pegboard Test (gPT)
In order to measure psychomotor speed, the Grooved 
Pegboard Test was administered. The task consists 
of placing 25 pegs in a linear order into their corre-
sponding holes in the least amount of time possible. 
The individual’s execution time is measured twice, 
once while using the dominant hand and once using 
the non-dominant hand.
Family pictures
To examine visuospatial learning and memory, the 
Family Picture subtest of the Wechsler Memory Scale 
was administered.40 A portrait that includes six family 
members (mother, father, grandmother, grandfather, 
daughter, son, and a dog) is shown at the beginning 
of the task while instructions are given. Subsequently, 
four  scenes  are  presented  for  10    seconds  each, 
  allowing  the  examinee  to  learn  important  aspects 
about the image, such as appearing members, their 
corresponding  positions  and  what  they  are  doing. 
After a 30 minute delay, the individual is encouraged 
to recall the information without viewing the picture. 
A cumulative percentage of the information remem-
bered from both trials is then obtained.
novel image/novel Location (ninL)
Novel Image/Novel Location is a visuospatial task 
that requires recognition of various natural and man-
made objects/images.22 The subject is presented with 
a series of 12 panels, each containing three pictures 
in four quadrants (A, B, C, and D), for eight seconds 
each. The images are all similar in complexity, but 
different in content. The subject is asked to remem-
ber the images on each panel as well as the position 
of each image on the panel. Immediately after, sub-
jects are presented with a series of 12 new panels. 
These new panels will either be identical to or have 
some slight variation compared to their counterparts 
in the first set. Each new panel may contain a variance 
in the positioning of one of the three images (novel 
location), or one of the three images may be different 
(novel image). The subject is asked to identify the 
new panel as either being identical to or containing 
a change in comparison to the first-viewed panel; in 
the latter case, the subject is asked to identify the 
change.  This  test  was  developed  and  copyrighted 
by Dr. Jacob Raber at Oregon Health and Science 
University.
Selected sub-tests of the Wechsler Adult 
intelligence Scale-iii, adapted Spanish 
version
The  scores  of  seven  selected  sub-scales  of  the 
Wechsler Adult Intelligence Scale (EIWA-III for its 
initials in Spanish) were used to obtain the Working 
Memory Index (WMI) and prorated Full Scale Intelli-
gence Quotient (FSIQ).41 The Working Memory Index 
was assessed by performance on the Arithmetic, Digit 
Span, and Letter-Number Sequencing sub-tests. The 
execution in these tasks depends upon the individual’s 
cognitive ability to assemble, hold, and manipulate 
information while performing a wide range of tasks, 
including comprehending, reasoning, and learning, in 
order to formulate an adequate response.42,43Spatial memory and coping in breast cancer survivors
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A prediction of an FSIQ from the EIWA-III was 
made using four selected sub-scales: Vocabulary and 
Similarities from the Verbal Scale and Block Design 
and Matrix Reasoning from the Performance Scale. 
Sums for standard scores were made independently 
for the Verbal and Performance sub-tests. The aver-
ages of the standard scores were multiplied by six 
for the Verbal Scale and by five for the Performance 
Scale. The multipliers are the total number of sub-
tests  on  each  scale  respectively. The  two  prorated 
standard scores were summed, and the resulting value 
was converted to Full Scale IQ using Table A.4 in 
appendix A of the EIWA-III manual.44
Memory island
The Memory Island (MI) is a virtual reality task based 
on the Morris water maze (Morris, 1985), created to 
assess visuospatial learning and memory.22,24,45 As is 
the case with the traditional pre-clinical water maze, 
the  MI  virtual  reality  task  has  learning  (visible), 
immediate-memory (hidden), and delayed-memory 
(probe) trials. The computer-generated virtual test 
consists of an island comprising of four quadrants 
that contain different target items. The participants 
navigate through the virtual island using a joystick 
while listening to nature sounds through a headphone 
(eg, birds singing, water flowing). During the vis-
ible portion of the task, participants are instructed to 
navigate the virtual island’s four quadrants in order 
to find different objects located next to large flags 
poles with brightly colored flags (Fig. 1). In the hid-
den trials, participants are asked to find (four times) 
one of the targets from the first set of trials, without 
the aid of a flag. If the participants are unable to 
locate the target after two minutes, an arrow appears 
at the top of the screen to guide them to the appro-
priate target. It is important to affirm that the initial 
performance, or first two minutes of the task, is the 
most appropriate measure of learning and memory 
(Fig. 1). Consequently, performance was examined 
based on cumulative distance (virtual units/seconds) 
to the target during the first two minutes in the learn-
ing (visible) and immediate-memory (hidden)   trials. 
After  15  minutes,  a  30-second  delayed-memory 
(probe) trial was assessed using time spent in the 
target  quadrant,  consistent  with  previous  studies. 
For the Puerto Rican population, the script and word 
prompts were translated to Spanish and modified to 
employ culturally appropriate language. Permission 
for the use of this program was obtained from Jacob 
Raber,  Ph.D.,  who  is  a  Professor  in  the  Depart-
ment of Neurology at Oregon Health and Science 
University.
COPe inventory
To assess the coping strategy most frequently used in 
the last year, a 60-item inventory was administered 
in Spanish.31,46–48 The responses were presented in a 
4-point scale and ranged from 1 (I usually don’t do 
this at all) to 4 (I usually do this a lot) covering 10 dif-
ferent coping tactics (eg, active coping, denial, plan-
ning). The scale was divided into two different ways 
of  coping,  emotion-focused  and  problem-focused 
strategies, with five coping tactics in each cluster.
Statistical analysis
Analyses were conducted using SPSS software, ver-
sion 17.0. A Fisher’s exact test was used to obtain an 
age distribution within groups. The Student’s t test 
was used to explore differences between cognitive 
performances within groups (BCSs and women with-
out  diagnoses)  in  standardized  assessments  (GPT, 
CPT, Working Memory Index, Prorated FSIQ, SRE, 
and Cope Inventory). A Repeated Measure (REM) 
Analysis  of  Variance  (ANOVA)  was  conducted  to 
evaluate (across trials) the participants’ velocity and 
performance (cumulative distance to target) during 
the visible and hidden trials of the MI tasks. The Wil-
coxon signed rank test was used to test the median 
differences (in the probe performance) between the 
percent of time spent in the target quadrant and all 
other quadrants. For all analyses, P , 0.05 was con-
sidered statistically significant.
Figure 1. Memory island visible screen shots. A representative picture of 
the seal target (with the flagpole) that appears during the visible trial; the 
arrow appears at the top of the screen after two minutes.Ayala-Feliciano et al
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Table 1. Sample characteristics.
  non-breast cancer Breast cancer survivors P
n 22 16
Age 46.7 ± 3.8 52.5 ± 2.0 0.10
Years of education 16.1 ± 0.7 15.3 ± 0.6 0.41
Percentage right-handed 86.4% 100% 0.08
Smokers 4.3% 0% 0.42
employment status 0.85
  Unemployed 26.3% 27.3%
  employed 73.7% 72.7%
Marital status 0.43
  Married 42.1% 64.3%
  Single 31.6% 28.6%
  Divorced 26.3% 7.1%
Income 0.12
 , $25,000 a year 33.3% 72.7%
 , $35,000 a year 26.7% 9.1%
 . $35,000 a year 40.0% 18.2%
Length of chemotherapy (months) 1.0 ± 0.3
Doses/cycle 3.3 ± 0.6
Years post-chemotherapy 5.6 ± 1.1
hormone treatment (tamoxifen) 60%
Types of chemotherapy
  Adriamycin only 25.0%
  Adriamycin and cytoxan 56.2%
  Methotrexate 6.2%
  Unknown chemotherapy 12.6%
chemotherapy and radiotherapy 12.6%
note: Mean ± SeM.
In order to further explore the relationship between 
neurocognitive performance and the effects of chemo-
therapy in BCSs, Step-wise multiple linear regression 
analysis were used to adjust by age and psychoso-
cial stress, age and problem-focused coping strate-
gies, or age and emotion-focused coping strategies. 
The adjusted partial correlation coefficients and the 
determination coefficients were used as measures of 
association.
Results
Study population
Table 1 contains the Socio-demographic information, 
number  of  years  post-chemotherapy,  type  of  treat-
ment, and number of treatment cycles received within 
the BCS group. The sample consisted of 16 BCSs and 
22 participants who had not received chemotherapy 
for BC or any other type of cancer. The age range of 
all of the participants was 30 to 64 years. BCSs mean 
age was 52.5 ± 2.0, and non-BCSs mean age was 
46.7 ± 3.8. All participants were female Puerto Ricans 
who were well educated and, primarily, employed at 
least part-time. The average time-lapse since BCSs 
had  received  chemotherapy  was  5.6  ±  1.1  years. 
Within  the  BCSs  group,  all  participants  received 
standard-dose chemotherapy for at least 3 weeks and 
up to 6 months. The median number of cycles of che-
motherapy ranged from 1 to 6 months with an aver-
age of 3.3 ± 0.6 cycles. Approximately 60% of BCSs 
received hormone replacement therapy (Tamoxifen) 
as part of their treatment.
group differences in neurocognitive 
performance
The results obtained from the comparison of the per-
formance of non-BCSs versus BCSs on measures of 
neurocognitive functioning are included in Table 2. 
No significant differences were obtained when com-
paring performance between the groups on measures 
of sustained attention (measured with CPT), picture Spatial memory and coping in breast cancer survivors
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Table 2. neurocognitive measures and psychosocial stress in non-breast cancer and breast cancer survivors.
neurocognitive measures non-breast cancer Breast cancer survivors t P
Attention
  CPT—overall non-clinical score 45.5 ± 3.23 48.7 ± 4.37 0.44 0.57
  Percentage ADD/ADhD 0.41 ± 0.1 0.38 ± 0.1 1.00 0.83
psychomotor speed
  grooved Pegboard Test—dominant 68.4 ± 1.8 80.9 ± 5.1 -2.31 0.02*
  grooved Pegboard Test—non-dominant 78.9 ± 1.8 86.6 ± 5.7 -1.05 0.16
Visuospatial learning and memory
  Family Pictures total score 89.1 ± 3.8 77.8 ± 6.2 0.46 0.13
  ninL novel image 11.5 ± 0.9 10.2 ± 1.4 -0.04 0.43
  ninL novel Location 11.0 ± 1.0 9.19 ± 1.5 0.33 0.48
  ninL total Score 54.5 ± 2.6 48.8 ± 3.0 0.82 0.16
eIWA-III selected sub-scales
  Arithmetic 11.1 ± 0.5 10.2 ± 0.6 0.58 0.25
  Digit Span 15.8 ± 4.0 12.4 ± 0.9 1.15 0.60
  Letter-number sequencing 12.0 ± 0.5 11.0 ± 0.7 1.51 0.28
  Working Memory index (eiWA-iii) 110.3 ± 2.6 111.3 ± 3.6 -0.05 0.82
  Vocabulary 12.0 ± 0.5 11.6 ± 0.7 1.16 0.64
  Similarities 12.7 ± 0.4 11.7 ± 0.9 1.24 0.22
  Block design 10.6 ± 0.6 10.7 ± 1.1 -0.38 0.93
  Matrix reasoning 15.2 ± 4.0 10.5 ± 0.9 1.07 0.48
  Prorated FSiQ (eiWA-iii) 110.4 ± 2.2 107.7 ± 5.0 0.54 0.59
notes: Mean ± SeM; *P , 0.05, statistically significant.
Abbreviations: CPT, Conners’ Continuous Performance Test; FSiQ, Full Scale iQ; eiWA-iii, Wechsler Adult intelligence Scale for Adults, Third ed.
recognition, visuospatial learning, or memory tasks 
(NINL, Family Pictures). However, statistically sig-
nificant  differences  in  GPT  means  were  observed, 
indicating a reduced psychomotor speed performance 
in BCSs (P , 0.02) as compared to the non-BCSs 
control group.
Selected  sub-scales  of  the  Wechsler  Adult  Intel-
ligence  Scale  (EIWA-III)  were  administered  to  both 
groups in order to determine whether there were cog-
nitive performance differences within groups.   Student’s   
t tests indicated that there were no differences in the 
WMI or individual sub-tests (arithmetic, digit span, let-
ter-number sequencing); nor were any differences found 
in the prorated FSIQ composite (vocabulary, similarities, 
block design, matrix reasoning) or individual sub-tests.
In order to identify possible group difference in the 
average velocity in the visuospatial learning (visible 
trials) and immediate-memory (hidden trials) sections 
of the MI, a Student’s t test was used. The results indi-
cated that there were no differences between groups 
on the average velocity (virtual units/sec) in either 
the visible (P = 0.48) or the hidden trials (P = 0.51). 
A Repeated Measure (REM) Analysis of Variance 
(ANOVA) assessing performance using cumulative 
distance to target in the first two minutes was used 
across trials to examine learning differences between 
BCSs and non-BCSs. Our findings indicate that there 
were no differences across the visible trials in average 
cumulative distance to the target (F = 1.72, P = 0.47, 
Fig. 2A–B). The performance during the visible tri-
als did improve as indicated by significant effects 
within the trial (F = 34.0, P , 0.001, Fig. 2A). The 
results indicate that BCSs were able to learn how to 
navigate to the fourth target, which improved perfor-
mance over the trials to a level similar to that of the 
non-BCSs participants.
During the hidden portion of the task, the subjects 
were asked to find the same target over four trials. 
A REM ANOVA for cumulative distance to the tar-
get across trials indicated that there were differences 
between groups in overall performance (F = 4.48, 
P  ,  0.05,  Fig.  2B,  D),  particularly  in  trial  three 
(P , 0.05, Fig. 2A). In the hidden trials, both groups 
demonstrated that practice resulted in improvements 
(F = 41.31, P , 0.0001, Fig. 2A).This data suggests 
that BCSs display reduced immediate-memory per-
formance; however, their performance improved over 
the course of the trials.Ayala-Feliciano et al
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Figure 2. Differences in Memory island performance between non-BC 
and BCSs. A) There were no differences in performance between groups 
during the visible trials. B) BCSs accumulated a higher than average 
cumulative target displacement during the hidden trials (*P , 0.05). c) 
non-BC subjects spent more time in the target quadrant during the probe 
trial (**P , 0.01 target vs. all other quadrants). BCSs did not spend more 
time in the target compared to the right quadrant.
After 15 minutes of the last hidden trail, delayed 
memory (probe trial) was assessed for thirty seconds. 
According to the results obtained by the Wilcoxon 
signed rank test, the non-BCSs spent more time in 
the  target  quadrant  during  the  delayed-memory 
(probe) trial (P , 0.00, target vs. all other quadrants, 
Fig.  2C).  However,  the  BCSs  who  had  undergone 
  chemotherapy did not spend more time in the target 
quadrant compared to the right quadrant (Fig. 2C), 
with only 50% of subjects displaying target quadrant 
preference (P , 0.04, Fig. 2C). T-tests indicate that 
82% of Non-BCs preferred the target quadrant (spent 
more than 50% of time in the target quadrant) with 
only 50% of the BC subjects displaying target quad-
rant preference (P , 0.04). Overall, our data show 
that participating BCSs who had undergone at least 
one month of chemotherapy experienced visuospatial 
memory impairments in the virtual reality MI task.
The analysis of the Spearman’s correlation dem-
onstrates strong associations between the MI task 
and other cognitive measures. The results indicate 
a highly significant association between the learn-
ing trial of MI and the Family Pictures total score 
(P , 0.007), as indicated in Table 3. The learning 
portion of the virtual reality task also correlates with 
other cognitive measures from the EIWA-III scale 
such as digit span, block design, matrix reasoning, 
WMI, and FSIQ. The immediate-memory portion of 
the task correlates with the EIWA-III in terms of the 
digit-span, block-design, and matrix-reasoning sub-
scales. Moreover, the delayed-memory task corre-
lated with GPT (dominant hand and non-dominant 
hand), Family Pictures, NINL Image, NINL Loca-
tion, and NINL total score. The results yield sta-
tistically significant correlations between the MI’s 
delayed-memory task and the EIWA-III sub-scales 
such  arithmetic,  block  design,  matrix  reasoning, 
and FSIQ.
Relationship between coping strategies 
and neurocognitive performance in 
breast cancer survivors
According  to  the  Student’s  t  tests  analysis  per-
formed, there is a statistically significant difference 
between the means obtained for both groups in the 
COPE inventory. The results reveal that the BCSs 
present higher denial-based coping strategies com-
pared to non-BCSs (P = 0.05), as shown in Table 4. 
Non-statistically  significant  trends  towards  higher 
levels  of  active  coping,  positive  reinterpretation, 
and overall emotion-focused composite scores were 
detected in BCSs.
When analyzing the results of the emotional cop-
ing composite and problem-focused   composite within Spatial memory and coping in breast cancer survivors
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all  participants,  significant  correlations  between 
  neurocognitive  measures  were  found.  These  also 
indicate  that  the  performance  on  the  MI  correlate 
with implemented coping strategies. Therefore, those 
women  who  performed  worse  during  the  learning 
(average visible, P , 0.02) and immediate-memory 
(average hidden, P , 0.007) trials had a tendency 
to  implement  emotion-focused  coping  strategies. 
Examining  the  individual  emotional  sub-scales  of 
the COPE Inventory, only denial increased in BCSs, 
which also correlated with lower immediate-memory 
performance  in  MI  (average  hidden:  Correlation 
Coefficient, 0.50, P , 0.003).
As  illustrated  in  Table  5,  those  women  who 
tended  to  perform  better  in  the  delayed-memory 
(probe) trial had a tendency to implement problem-
focused  coping  strategies  (P  ,  0.01). A  statisti-
cally significant correlation was observed between 
the    problem-focused  coping  strategy  and  GPT 
(P  =  0.05).  Both  the  planning  (probe:  Correla-
tion Coefficient, 0.41, P , 0.02) and the restraint 
(probe:  Correlation  Coefficient,  0.42,  P  ,  0.02) 
sub-scales  individually  correlated  to  increased 
delayed-  memory performance. Furthermore, those 
women  with  an  average  prorated  FSIQ  reported 
higher scores in the problem-focused coping strate-
gies (P , 0.03), particularly in the planning sub-
scale (Correlation Coefficient, 0.42, P , 0.02). No 
significant differences were seen in the attention, 
WMI, or other visuospatial learning and memory 
tasks (NINL, Family Picture).
Additionally,  Step-wise  multiple  linear  regres-
sions were generated in order to examine the cor-
relation between women with history of BC who 
received  chemotherapy  and  cognitive  measures 
adjusted by age and emotional coping or problem 
coping strategies. Only one significant relationship 
between problem focused coping and reduced per-
formance in the GPT with their dominant hand in 
BCSs was observed (P , 0.03). This suggests there 
is a 9.99% chance that reduced psychomotor speed 
performance  in  BCSs  was  due  to  chemotherapy. 
No  statistical  significance  was  observed  between 
women who received chemotherapy and other neu-
rocognitive measures with respect to age or coping 
strategies used.
Table 3. Spearman’s correlations between Memory island and other cognitive and neuropsychological measures.
neurocognitive measures Visible  
cumulative distance  
to target
Hidden  
cumulative distance  
to target
probe  
% time in target  
quadrant
Attention
  CPT—overall non-clinical score 0.11 (0.52) 0.18 (0.29) -0.24 (0.16)
psychomotor speed
  grooved Pegboard test—dominant -0.06 (0.73) 0.17 (0.30) -0.38 (0.02)*
  grooved Pegboard test—non-dominant 0.26 (0.13) 0.13 (0.46) -0.44 (0.009)**
Visuospatial learning and memory
  Family Pictures total score -0.45 (0.007)** 0.20 (0.22) 0.57 (,0.001)***
  ninL novel image -0.27 (0.10) -0.02 (0.93) 0.38 (0.03)*
  ninL novel iocation -0.01 (0.94) -0.15 (0.39) 0.39 (0.03)*
  ninL Total Score -0.24 (0.15) -0.26 (0.13) 0.41 (0.02)*
eIWA-III selected sub-scales
  Arithmetic -0.25 (0.16) -0.25 (0.11) 0.54 (0.003)**
  Digit span -0.35 (0.04)* -0.35 (0.04)* 0.02 (0.89)
  Letter-number sequencing 0.05 (0.78) 0.05 (0.78) 0.04 (0.84)
  Working Memory index (eiWA-iii) -0.45 (0.01)** -0.23 (0.21) 0.08 (0.67)
  Vocabulary -0.22 (0.20) -0.05 (0.78) 0.21 (0.24)
  Similarities -0.24 (0.15) -0.20 (0.22) 0.20 (0.26)
  Block design -0.36 (0.03)* -0.36 (0.03)* 0.64 (,0.001)***
  Matrix reasoning -0.39 (0.02)* -0.40 (0.02)* 0.43 (0.01)**
  Prorated FSiQ (eiWA-iii) -0.36 (0.04)* -0.11 (0.52) 0.40 (0.02)*
notes: Correlation coefficient (P value); *P , 0.05; **P , 0.01; ***P , 0.001, statistically significant.
Abbreviations: CPT, Conners’ Continuous Performance Test; FSiQ, Full Scale iQ; eiWA-iii, Wechsler Adult intelligence Scale for Adults, Third ed.Ayala-Feliciano et al
126  Breast Cancer: Basic and Clinical Research 2011:5
Discussion
In  the  present  study,  different  neuropsychological 
domains were assessed in order to explore whether 
chemotherapy and/or radiation treatment have a det-
rimental  effect  on  cognitive  performance  in  long-
term BCSs. The results from the MI tasks (reduced 
performance in immediate and delayed memory) sug-
gest that BC treatment (chemotherapy and/or radia-
tion) might induce cognitive deficits in BCSs. Using 
  analyses  similar  to  those  employed  in  pre-clinical 
rodent  models  of  the  quadrant-based  water  maze, 
we  examined  performance  during  learning,  imme-
diate memory, and delayed (15 minutes) memory in 
MI. Our data indicate the BCSs who had undergone 
treatment were able to learn the MI task. However, 
survivors displayed mild impairments in the immedi-
ate memory compared to controls, though improving 
their performance with multiple trials. Only 50% of 
Table 4. Mean differences in coping strategies of non-breast cancer and breast cancer survivors.
coping strategies non-breast cancer Breast cancer survivors P
problem-focused
  Active coping 12.3 ± 0.3 13.4 ± 0.5 0.06
  Planning 13.4 ± 0.4 13.4 ± 0.5 0.91
  Suppression of competing activities 9.9 ± 0.4 10.7 ± 0.5 0.24
  Restraint 11.1 ± 0.6 10.0 ± 0.7 0.22
  Use of instrumental social support 12.0 ± 0.7 13.1 ± 0.5 0.21
  Total 59.1 ± 1.6 60.7 ± 1.6 0.51
emotion-focused
  Use of emotional social support 11.1 ± 0.7 11.8 ± 0.5 0.49
  Positive reinterpretation and growth 12.8 ± 0.5 14.0 ± 0.5 0.09
  Acceptance 11.3 ± 0.5 11.6 ± 0.7 0.69
  Denial 5.9 ± 0.4 7.6 ± 0.8 0.05*
  Religious coping 12.9 ± 0.8 12.8 ± 1.0 0.93
  Total 53.7 ± 1.1 57.8 ± 7.7 0.08
Other scales
  Mental disengagement 9.2 ± 0.4 9.4 ± 0.5 0.82
  Behavioral disengagement 6.5 ± 0.4 7.1 ± 0.6 0.40
  Focus on and venting of emotions 10.8 ± 0.6 10.0 ± 0.6 0.34
  humor 9.0 ± 0.6 8.3 ± 1.0 0.54
  Substance use 5.0 ± 0.6 4.1 ± 0.1 0.21
notes: Mean ± SeM; *P , 0.05, statistically significant.
Table 5. Spearman’s correlations between coping strategies among neurocognitive measures.
neurocognitive measures emotion-focused coping strategy problem-focused coping strategy
Grooved pegboard test
  Dominant hand 0.20 (0.22) -0.21 (0.21)
  non-dominant hand 0.11 (0.51) -0.32 (0.05)*
Attention (CPT) 0.17 (0.29) 0.29 (0.07)
Memory Island
  Visible 0.40 (0.02)* -0.19 (0.26)
  hidden 0.45 (0.007)** -0.03 (0.87)
  Probe Target -0.11 (0.54) 0.52 (0.002)**
Family Pictures total -0.27 (0.11) 0.29 (0.08)
nInL Total
Working Memory index (eiWA-iii) -0.16 (0.36) 0.17 (0.35)
Prorated FSiQ (eiWA-iii) -0.29 (0.07) 0.36 (0.03)*
notes: Correlation coefficient (P value); *P , 0.05; **P , 0.01, statistically significant.
Abbreviations: CPT, Conners’ Continuous Performance Test; eiWA-ii, Wechsler Adult intelligence Scale for Adults, Third ed., FSiQ, Full Scale intelligence 
Quotient.Spatial memory and coping in breast cancer survivors
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the BCSs navigated close to the target in the delayed 
memory trial compared to 82% of the healthy non-BC 
subjects.  Our  evidence  mimics  the  animal  studies, 
which  also  demonstrated  immediate  and  delayed 
memory impairments in the water maze.10–12 Though 
this is a small pilot study, our data supports further 
investigations using tasks such as MI in order to vali-
date the effects of pre-clinical testing of chemother-
apy agents on long-term cognitive deficits.
Some studies reported mild to moderate levels of 
impairment in attention in BCSs.20,49,50 However, the 
absence of differences among groups in our study is 
similar to other reported findings.18,50,51 The results 
obtained in the EIWA-III for the verbal WMI and the 
prorated FSIQ yield no differences in performance 
between  groups. The  absence  of  intragroup  differ-
ences is probably due to small sample size or to other 
confounding factors. In addition, there was no indica-
tion of age effects in our sample on any assessment 
according to multiple linear regressions.
With regards to the most prevalent coping strate-
gies used by BCSs, our study employed the COPE 
inventory.30,46–48 Consistent with other studies, trends 
towards higher levels of active coping, positive rein-
terpretation and growth, and overall emotion-focused 
composite scores were obtained from BCSs.32,34 No 
differences were observed in religious coping strate-
gies among groups. This may be explained by the fact 
that members of most Latin-American cultures are 
heavily influenced by religious beliefs and frequently 
resort to religion as a means of dealing with stress-
ful situations.32 Literature regarding coping mecha-
nisms in Latin BCSs indicates that these individuals 
have very high levels of religiosity and spirituality, 
which have been shown to be related to greater levels 
of overall well-being.52 In terms of problem-focused 
coping, only active coping was found to be slightly 
greater in BCSs. However, this was not found to be 
highly significant. Therefore, survivors showed a pre-
dominantly emotion-focused style of coping.
Women who implemented emotion-focused strat-
egies showed a decrease in learning and immediate 
visuospatial  memory  performance,  whereas  those 
who engaged in problem-focused strategies displayed 
greater memory retention in the delayed-memory trial 
of MI. Furthermore, the results of this exploratory 
study indicate a slower psychomotor speed in BCSs 
when they used their dominant hands. Those women 
who demonstrated reduced motor-speed performance 
on the GPT showed a tendency to employ problem-
focused strategies according to the linear regressions. 
The reduced psychomotor speed was not necessarily 
indicative of poor performance, but rather may reflect 
a more cautious approach.
Although it was not qualitatively accounted for 
during testing sessions, we can infer that the neu-
ropsychological battery was interpreted as a stress-
ful situation by participants due to its novelty and 
  complexity.53  According  to  our  findings,  we  can 
speculate that those women with a tendency to uti-
lize problem-focused coping strategies were able to 
attempt  and  execute  cognitive  tasks  in  a  stepwise 
fashion. They were able to handle the complexity of 
the tasks at hand by inhibiting other activities. This 
approach  facilitated  initiation  and  planning  strate-
gies, allowing them to perform better in neurocog-
nitive tasks. However, those who are more inclined 
to engage in emotional coping strategies (eg, denial) 
probably need more time to structure and execute a 
plan in order to deal with stressful situations. We can 
hypothesize that those with a tendency to emotion-
ally cope with stressful situations might display dif-
ficulties  concentrating  and  rapidly  processing  new 
information and therefore will display lower scores 
in neurocognitive tasks.53
We confronted several limitations. In the current 
investigation,  the  sample  size  of  both  groups  was 
small, probably affecting some of the statistical anal-
yses performed. We did not account for information 
regarding  premorbid  cognitive  functioning  before, 
during, or immediately after chemotherapy exposure, 
and this may be a concern for other sources of vari-
ability. Information regarding genetic risk factors in 
cognitive deficits such as the presence of apolipopro-
tein E (apoE) allele 4 was not integrated in our data 
analyses due to the insufficient number of partici-
pants. Previous studies indicate that those BCSs who 
are  apoE4  carriers  demonstrate  increased  memory 
deficits after chemotherapy compared to non-carrier 
cancer survivors.54 The use of a larger sample may 
result in other associations between neurocognitive 
measures and stress and coping strategies that were 
not observed in this study.
For future investigations, a longitudinal study 
would  be  appropriate  in  order  to  explore  the 
impact  of  various  cancer  treatment  modalities Ayala-Feliciano et al
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such as a high or standard dose of chemotherapy, 
  radiotherapy,  or  hormonal  treatment;  which  can 
also be compared with breast cancer patients who 
did not received any treatment. All of the EIWA-
III sub-scales available in the neuropsychological 
battery could be used in order to reassess the statis-
tical significance of the FSIQ prorated   composite. 
  Furthermore, the use of MI should be further vali-
dated in order to examine the long-term effects on 
general  cognitive  performance  and  visuospatial 
learning and memory in cancer survivors. Also, it 
would be important to include additional tasks that 
assess executive functions and some verbal learn-
ing and memory tasks in order to explore other 
neuropsychological domains that were not consid-
ered for in this study.
As  individual  differences  were  not  accounted 
for in our analysis, it would be valuable to corre-
late neuropsychological scores with possible struc-
tural changes among frontal, parietal and temporal 
association areas utilizing human brain imaging.54,55 
Results  of  past  investigations  utilizing  magnetic 
resonance diffusion tensor imaging in combination 
with detailed cognitive assessment indicate reduced 
white matter integrity in frontal and parietal regions 
in  BC  patients  compared  with  healthy  control  or 
non-chemotherapy treated patients.54 It is important 
to  further  evaluate  the  associations  between  cop-
ing strategies and neurocognitive measures to better 
improve cognitive functionality and therefore qual-
ity of life. This may be accomplished by gathering 
qualitative information in order to understand how 
psychosocial  stress  is  perceived  and  what  coping 
strategies are being employed by long-term BCSs. 
This may lead to the exploration of specific factors 
and potential mechanisms related to the effects of 
chemotherapy  agents  in  neurocognitive  functions 
and  their  impact  on  psychological  well-being  in 
long-term cancer survivors. Future research should 
replicate this study with subjects of different eth-
nicities  to  determine  the  generalizability  of  these 
findings.
Our results showed mild to moderate impairment 
in  visuospatial  memory  and  reduced  motor-speed 
performance in BCSs. This exploratory study may 
provide the first evidence that suggests that MI may 
be an appropriate task to further assess the cognitive 
effects of chemotherapy on visuospatial memory in 
BCSs, allowing for the detection of problems that can 
interfere with daily living and identifying individu-
als who could benefit from therapeutic interventions 
such as neurocognitive rehabilitation. This battery of 
tests can be further developed to assess the utility of 
different  neurocognitive  therapies  on  the  recovery 
of BCSs.
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